Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model

Medical Oncology

Volumn 16, Issue 4, 1999, Pages 267-278

  Kusnierczyk, H ^a   Pajtasz Piasecka, E ^a   Radzikowski, C ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Antitumour effects; Bromofosfamide; Chemo immunotherapy; Cyclophosphamide; Interleukin 2; MC 38 colon tumour

Indexed keywords

CBM 11; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IFOSFAMIDE; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR IMMUNITY;

EID: 0033393226     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02785873     Document Type: Article

References (47)